Phase I-II FIH TROP2 ADC Advanced Unresectable/Metastatic Solid Tumors Refractory to Standard Therapies
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Ovarian Epithelial Cancer
Age: Between 18 - 100 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required